Back
Ryde Group Ltd. Vs. Halozyme Therapeutics, Inc. Sector Stock Comparison
Sell
24
RYDE
Ryde Group Ltd.
Last Price:
$0.29
Seasonality Move:
-15.94%
Buy
65
HALO
Halozyme Therapeutics, Inc.
Last Price:
$68.87
Seasonality Move:
5.49%
Sell
24
Ryde Group Ltd. (RYDE)
is a Sell
Is Ryde Group Ltd. a Buy, Sell or Hold?
-
The current Ryde Group Ltd. [RYDE] share price is $0.28. The Score for RYDE is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
RYDE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Halozyme Therapeutics, Inc. (HALO)
is a Buy
Is Halozyme Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Halozyme Therapeutics, Inc. [HALO] share price is $68.87. The Score for HALO is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
HALO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RYDE Stock Price Chart
What is Ryde Group Ltd.'s stock price today?
-
The Ryde Group Ltd. share price today is $0.28The current trend is relatively stagnant and RYDE is experiencing selling pressure, which indicates risk of future bearish movement.
HALO Stock Price Chart
What is Halozyme Therapeutics, Inc.'s stock price today?
-
The Halozyme Therapeutics, Inc. share price today is $68.87Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HALO is experiencing buying pressure, which is a positive indicator for future bullish movement.
RYDE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 29.32 | Sell |
| Chaikin Money Flow: | -107114 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.37 - 0.51) | Sell |
| Bollinger Bands (100): | (0.33 - 0.51) | Sell |
HALO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 58.98 | Buy |
| Chaikin Money Flow: | 516593 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (63.07 - 70.31) | Buy |
| Bollinger Bands (100): | (64.7 - 73.66) | Sell |
RYDE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.35 | Sell |
| 20-day SMA: | 0.43 | Sell |
| 50-day SMA: | 0.48 | Sell |
| 200-day SMA: | 0.34 | Sell |
| 8-day EMA: | 0.25 | Buy |
| 20-day EMA: | 0.15 | Buy |
| 50-day EMA: | 0.07 | Buy |
| 200-day EMA: | 0.02 | Buy |
HALO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 67.06 | Buy |
| 20-day SMA: | 65.42 | Buy |
| 50-day SMA: | 67.19 | Buy |
| 200-day SMA: | 63.54 | Buy |
| 8-day EMA: | 67.24 | Buy |
| 20-day EMA: | 66.58 | Buy |
| 50-day EMA: | 67.18 | Buy |
| 200-day EMA: | 63.87 | Buy |
Ryde Group Ltd. Earnings Growth & RYDE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.
Halozyme Therapeutics, Inc. Earnings Growth & HALO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.13 per share, and an increase next year of $1.88 per share.
Ryde Group Ltd. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Halozyme Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||